Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Motilal Oswal Securities Ltd.
$58.00
Provider: Spark Capital Advisors(India) Private Limited
$35.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GlaxoSmithKline Consumer Healthcare Ltd Updates On Open Offer From GlaxoSmithKline plc's GlaxoSmithKline Pte Ltd


Thursday, 7 Feb 2013 12:38am EST 

HSBC Securities and Capital Markets (India) Pvt Ltd (Manager to the Open Offer) for and on behalf of GlaxoSmithKline Pte Ltd (GSK Pte or the Acquirer) along with Horlicks Ltd (Horlicks) and GlaxoSmithKline plc (GSK plc) in their capacity as persons acting in concert (each entity individually referred to as PAC and together referred to as PACs) announced that post offer announcement to the shareholders of GlaxoSmithkline Consumer Healthcare Ltd (Target Company), in respect of the Voluntary Open Offer (Open Offer) for the acquisition of 13,389,410 Shares representing 31.84% of the Voting Share Capital from the public shareholders of the Target Company. 

Company Quote

5827.25
8.55 +0.15%
26 Dec 2014